• 71 Hits
  • 検索条件 : 絞込み (MeSH = Neoplasms / drug therapy*)
生物種 リソース名 タイトル
ヒト・動物細胞 B16 melanoma 4A5(RCB0557) , HL60(RCB0041) Melanogenesis-inhibitory and cytotoxic activities of diarylheptanoids from Acer nikoense bark and their derivatives.
ヒト・動物細胞 MMAc·SF(RCB1200) Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy.
ヒト・動物細胞 Lu-165(RCB1184) SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
ヒト・動物細胞 HeLa S3 , A549 , PC-3 Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.
ヒト・動物細胞 HEp-2(RCB1889) CCL299, a Benzimidazole Derivative Induces G1 Phase Arrest and Apoptosis in Cancer Cells.
ヒト・動物細胞 HeLa , A549 , MCF7(RCB1904) , MKN74(RCB1002) , A431 , PANC-1(RCB2095) , MIA Paca2(RCB2094) , 1B2C6(RCB0795) , 1C3D3(RCB0796) Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
ヒト・動物細胞 EBC-1(RCB1965) PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
ヒト・動物細胞 Lu99(RCB1900) Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
ヒト・動物細胞 OV2944-HM-1(RCB1483) Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
ヒト・動物細胞 MKN45(RCB1001) Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
ヒト・動物細胞 HGC-27(RCB0500) Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.
ヒト・動物細胞 B16F10(RCB2630) Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.
ヒト・動物細胞 LLC(RCB0558) , Colon-26(RCB2657) , B16/BL6(RCB2638) , OP9(RCB1124) Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact.
ヒト・動物細胞 Ba/F3 Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers.
ヒト・動物細胞 WERI-Rb-1(RCB2146) Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells.
ヒト・動物細胞 KP4(RCB1005) Mannose impairs tumour growth and enhances chemotherapy.
ヒト・動物細胞 Colon-26(RCB2657) , B16/BL6(RCB2638) Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.
ヒト・動物細胞 KP4(RCB1005) First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors.
ヒト・動物細胞 KP4(RCB1005) ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.
ヒト・動物細胞 Sa3(RCB0980) Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.